This proposal seeks to further understanding of an essential component of the skin immune system, the cathelicidin antimicrobial peptides. The absence of cathelicidin is associated with disease in animals, and infections in humans with atopic dermatitis. The precise identity of the cathelicidin peptides in normal and diseased.skin is not known. Also unknown are the host proteases produced in the skin that are responsible for the activation of cathelicidins and the bacterial proteases that degrade cathelicidins. to enhance their virulence. The current proposal will test the hypothesis that the skin generates a unique array of cathelicidin peptides by a strictly regulated system of proteolytic activation that is in balance with pathogen proteases. Understanding proteolysis of cathelicidins will provide a frameworkfor modification of function to enhance resistance to infection and modify potential deleterious host inflammatory effects of these peptides.
The Specific Aims are: 1. Identify cathelicidins peptide products produced by keratinocytes and whole skin a. Identify peptides generated by cultured keratinocytes b. Identify and quantify peptides in normal skin and psoriasis 2. Define cathelicidin processing in skin by identifying keratinocyte-specific processing enzymes. a. Purify enzymes responsible for cleavage of hCAP18 to release the cathelin prodomain b. Purify enzymes that cleave cathelicidin peptides to products determined in Aim 1 c. Confirm enzyme activity in cell and animal models 3. Determine if cathelicidin proteolysis is a virulence mechanism for an invasive bacterial skin pathogen a. Fully characterize GAS proteolytic degradation of cathelicidins and corresponding AMP resistance b. Determine the contribution of cathelicidin degradation to GAS virulence in invasive skin infection c. Assess if the cathelin prodomain serves to protect mature cathelicidin from proteolytic degradation Accomplishing the aims of this proposal will impact public health by providing a greater understanding of how we fight microbial infections and how bacteria try to avoid our immune system. This work will suggest novel approaches for fighting infectious disease of the skin.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Project (R01)
Project #
5R01AR052728-04
Application #
7568902
Study Section
Arthritis, Connective Tissue and Skin Study Section (ACTS)
Program Officer
Cibotti, Ricardo
Project Start
2006-04-12
Project End
2010-01-31
Budget Start
2009-02-01
Budget End
2010-01-31
Support Year
4
Fiscal Year
2009
Total Cost
$300,756
Indirect Cost
Name
Veterans Medical Research Fdn/San Diego
Department
Type
DUNS #
933863508
City
San Diego
State
CA
Country
United States
Zip Code
92161
Kumaraswamy, Monika; Do, Carter; Sakoulas, George et al. (2018) Listeria monocytogenes endocarditis: case report, review of the literature, and laboratory evaluation of potential novel antibiotic synergies. Int J Antimicrob Agents 51:468-478
Kulkarni, Nikhil N; Adase, Christopher A; Zhang, Ling-Juan et al. (2017) IL-1 Receptor-Knockout Mice Develop Epidermal Cysts and Show an Altered Innate Immune Response after Exposure to UVB Radiation. J Invest Dermatol 137:2417-2426
Adase, Christopher A; Borkowski, Andrew W; Zhang, Ling-Juan et al. (2016) Non-coding Double-stranded RNA and Antimicrobial Peptide LL-37 Induce Growth Factor Expression from Keratinocytes and Endothelial Cells. J Biol Chem 291:11635-46
Cole, Jason N; Nizet, Victor (2016) Bacterial Evasion of Host Antimicrobial Peptide Defenses. Microbiol Spectr 4:
Kumaraswamy, Monika; Lin, Leo; Olson, Joshua et al. (2016) Standard susceptibility testing overlooks potent azithromycin activity and cationic peptide synergy against MDR Stenotrophomonas maltophilia. J Antimicrob Chemother 71:1264-9
MacLeod, Daniel T; Nakatsuji, Teruaki; Wang, Zhenping et al. (2015) Vaccinia virus binds to the scavenger receptor MARCO on the surface of keratinocytes. J Invest Dermatol 135:142-150
Ma, Gary S; Aznar, Nicolas; Kalogriopoulos, Nicholas et al. (2015) Therapeutic effects of cell-permeant peptides that activate G proteins downstream of growth factors. Proc Natl Acad Sci U S A 112:E2602-10
Zhang, Ling-juan; Guerrero-Juarez, Christian F; Hata, Tissa et al. (2015) Innate immunity. Dermal adipocytes protect against invasive Staphylococcus aureus skin infection. Science 347:67-71
Nakagawa, Yukinobu; Gallo, Richard L (2015) Endogenous intracellular cathelicidin enhances TLR9 activation in dendritic cells and macrophages. J Immunol 194:1274-84
Borkowski, Andrew W; Kuo, I-Hsin; Bernard, Jamie J et al. (2015) Toll-like receptor 3 activation is required for normal skin barrier repair following UV damage. J Invest Dermatol 135:569-578

Showing the most recent 10 out of 91 publications